abstract |
The object of the present invention is to provide a method for predicting the risk of developing cancer. DNA samples were prepared from the blood and cancer tissues of 2,480 cancer patients, and the base sequence analysis of the exon site was performed using NGS, and 7 of the above cancer patients were confirmed. It has D49H mutation and A159D mutation which are germ cell mutations. |